Carlijn Voermans

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications

Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial.

Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial.

Journal: The Lancet. Oncology
Published: November 20, 2025

Protective Effects of Heme Oxygenase-1 Expression in Patients and Mice with Acute Graft-Versus-Host Disease?

Protective Effects of Heme Oxygenase-1 Expression in Patients and Mice with Acute Graft-Versus-Host Disease?

Journal: Stem cells and development
Published: March 13, 2025

PEGylated Granulocyte Colony-Stimulating Factor and Plerixafor Enhance Autologous Stem and Progenitor Cell Mobilization and Transplantation in Pediatric Patients.

PEGylated Granulocyte Colony-Stimulating Factor and Plerixafor Enhance Autologous Stem and Progenitor Cell Mobilization and Transplantation in Pediatric Patients.

Journal: Stem cells and development
Published: January 16, 2025

Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trial.

Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trial.

Journal: The British journal of surgery
Published: December 24, 2024

Generation of human ILC3 from allogeneic and autologous CD34+ hematopoietic progenitors toward adoptive transfer.

Generation of human ILC3 from allogeneic and autologous CD34+ hematopoietic progenitors toward adoptive transfer.

Journal: Cytotherapy
Published: July 23, 2023

Source of hematopoietic progenitor cells determines their capacity to generate innate lymphoid cells ex vivo.

Source of hematopoietic progenitor cells determines their capacity to generate innate lymphoid cells ex vivo.

Journal: Cytotherapy
Published: July 17, 2023

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.

Journal: The New England journal of medicine
Published: December 08, 2022

Optimized Guide RNA Selection Improves Streptococcus pyogenes Cas9 Gene Editing of Human Hematopoietic Stem and Progenitor Cells.

Optimized Guide RNA Selection Improves Streptococcus pyogenes Cas9 Gene Editing of Human Hematopoietic Stem and Progenitor Cells.

Journal: The CRISPR journal
Published: September 28, 2022

Cell-free DNA levels are increased in acute graft-versus-host disease.

Cell-free DNA levels are increased in acute graft-versus-host disease.

Journal: European journal of haematology
Published: January 09, 2022

Bone Marrow Harbors a Unique Population of Dendritic Cells with the Potential to Boost Neutrophil Formation upon Exposure to Fungal Antigen.

Bone Marrow Harbors a Unique Population of Dendritic Cells with the Potential to Boost Neutrophil Formation upon Exposure to Fungal Antigen.

Journal: Cells
Published: August 27, 2021

Presence of innate lymphoid cells in allogeneic hematopoietic grafts correlates with reduced graft-versus-host disease.

Presence of innate lymphoid cells in allogeneic hematopoietic grafts correlates with reduced graft-versus-host disease.

Journal: Cytotherapy
Published: April 19, 2021

Heme oxygenase-1: Equally important in allogeneic hematopoietic stem cell transplantation and organ transplantation?

Heme oxygenase-1: Equally important in allogeneic hematopoietic stem cell transplantation and organ transplantation?

Journal: Transplant immunology
Published: March 03, 2021
Showing 1-12 of 41

Last Updated: 09/26/2026